S*Bio is a Singapore-based biotech company founded in 2000 and operating as a subsidiary of Chiron Corporation Limited. Specializing in Biotechnology and Pharmaceutical industries, the company is focused on pioneering the future of cancer treatment through innovative small molecule drugs. The latest investment of $5.00M through a Private Equity Round took place on 23 September 2010 and was made by Mitsui Global Investment. S*BIO Pte, Ltd. has been dedicated to discovering and clinically developing novel targeted small drugs to treat cancer, serving the biotechnology industry in Singapore.
No recent news or press coverage available for S*Bio.